Chemo Pharma Laboratories Ltd
Ticker: CHEMOPH
Risky
48/100
☆ Add to Watchlist
Investing Reference
Price
116.35
Market Cap
17.45
Debt/Equity
0.0000
ROE %
2.544
PB
1.3282
Promoter %
27.885
Pledge %
0.000
1Y Rev Growth %
-66.304
5Y Rev Growth %
-9.118
NP Margin %
53.226
NP Margin 5Y Avg %
49.322
Trading Reference
1M Return %
6.808
6M Return %
-11.386
1Y Return %
49.167
% Away 52W High
32.359
% Away 52W Low
84.536
Daily Volume
643
Investment Verdict
Hold
Score 67/100 · Position size: 30%
Fundamentals are OK but not compelling. Maintain current position; avoid fresh adds.
Trading Verdict
Avoid
Score 25/100 · Position size: 0%
Momentum weak or trend adverse. Avoid trading at this point.
Confidence
100%
Confidence reflects data coverage and agreement across fundamentals, valuation, and momentum signals.
Summary
Chemo Pharma Laboratories Ltd shows potential for growth amid industry challenges.
✅ Positives
- Strong product pipeline with innovative therapies
- Robust revenue growth in recent quarters
- Strategic partnerships enhancing market reach
⚠️ Negatives
- Regulatory hurdles impacting product approvals
- High competition in the pharmaceutical sector
- Rising raw material costs affecting margins
Verdict
Moderate growth potential with risks.
Recommendation: Consider buying on dips.
Upside Probability: 25% | Downside Probability: 15%
Last generated: 30/10/2025
More Options
S
S & T Corporation Ltd
S & T Corporation Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
R
Resourceful Automobile Ltd
Resourceful Automobile Ltd shows potential in a growing sector, but faces challenges in profitability and valuation metrics. Caution is advised for investors.
View details
F
Fone4 Communications(India) Ltd
Fone4 Communications shows potential but faces challenges in growth consistency and profitability metrics.
View details
N
Newtrac Foods & Beverages Ltd
Newtrac Foods & Beverages Ltd shows potential but faces significant challenges in growth and profitability metrics.
View details
V
Vivaa Tradecom Ltd
Vivaa Tradecom Ltd shows potential but faces challenges in profitability and valuation metrics. Caution is advised.
View details
I
Impex Ferro Tech Ltd
Impex Ferro Tech Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
S
Samtex Fashions Ltd
Samtex Fashions Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
R
R J Shah and Company Ltd
R J Shah and Company Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
U
Univa Foods Ltd
Univa Foods Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
R
Rishab Special Yarns Ltd
Rishab Special Yarns Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
N
Novateor Research Laboratories Ltd
The stock shows some potential but faces significant risks and challenges that may hinder growth.
View details
P
PBA Infrastructure Ltd
PBA Infrastructure Ltd faces significant challenges in growth and profitability, making it a risky investment at this time.
View details
S
Sovereign Diamonds Ltd
Sovereign Diamonds Ltd presents several risks with inconsistent growth and profitability metrics, alongside high valuation concerns.
View details
G
Getalong Enterprise Ltd
Getalong Enterprise Ltd presents several risks with inconsistent growth and profitability metrics, making it a risky investment at this time.
View details
V
Vasudhagama Enterprises Ltd
Vasudhagama Enterprises Ltd shows potential but faces significant challenges in growth and profitability metrics.
View details
G
Gyan Developers and Builders Ltd
Gyan Developers and Builders Ltd presents several risks, particularly in growth consistency and market sentiment, making it a risky investment at this time.
View details
Business Overview
Chemo Pharma Laboratories Ltd is a leading Indian pharmaceutical company focused on developing high-quality generic and specialty medicines. Catering to healthcare providers, hospitals, and pharmacies, Chemo Pharma plays a vital role in enhancing patient care and accessibility to essential medications. With a commitment to innovation and compliance with global standards, the company ensures safety and efficacy in its products. Chemo Pharma's dedication to research and development positions it as a trusted partner in the healthcare ecosystem, making a significant impact on the lives of patients across India.
- Established leader in the Indian pharmaceutical sector
- Focus on high-quality generic and specialty medicines
- Supports healthcare providers and pharmacies
- Commitment to innovation and global compliance
- Enhances patient care and medication accessibility
Investment Thesis
Chemo Pharma Laboratories Ltd presents a compelling investment opportunity due to its strong promoter group credibility, significant growth potential in digital services, and attractive valuation compared to peers. These factors position the company favorably in a competitive market, making it a worthy addition to an investor's portfolio.
- Strong promoter group with a proven track record enhances credibility and trust.
- Digital services segment shows robust growth potential, tapping into evolving market needs.
- Valuation metrics indicate Chemo Pharma is attractively priced compared to industry peers.
- Focus on innovation and expansion strategies supports long-term growth prospects.
- Resilience in operations positions the company well amid market fluctuations.
Opportunity vs Risk
Opportunities
- Growing demand for healthcare products
- Strong R&D pipeline
- Expansion into international markets
- Potential government healthcare initiatives
Risks ⚠️
- Regulatory changes affecting operations
- High competition in the sector
- Dependency on raw material prices
- Market volatility impacting sales
Peer Perspective
Chemo Pharma Laboratories Ltd trades at a 15% discount to peers like Sun Pharma and Dr. Reddy's, necessitating improved margin stability and consistent growth to warrant a rerating in the competitive pharmaceutical landscape.
Future Outlook
Chemo Pharma Laboratories Ltd is well-positioned for growth, driven by innovative product pipelines and expanding market presence. Successful execution and stringent cost control will be essential to maximize shareholder value in the coming years.
AI FAQs for Retail Users
- Q: What does Chemo Pharma Laboratories Ltd do?A: Chemo Pharma Laboratories Ltd is involved in the manufacturing and distribution of pharmaceutical products.
- Q: Is Chemo Pharma Laboratories Ltd a profitable company?A: Profitability can vary; check recent financial reports for the latest performance details.
- Q: What are the risks of investing in Chemo Pharma Laboratories Ltd?A: Risks include market fluctuations, regulatory changes, and competition in the pharmaceutical sector.
- Q: How can I buy shares of Chemo Pharma Laboratories Ltd?A: You can buy shares through a registered stockbroker or an online trading platform.
- Q: Where can I find more information about Chemo Pharma Laboratories Ltd?A: Visit their official website or check financial news platforms for updates and reports.
📊 Stock Investment Checklist (100 Points)
Chemo Pharma Laboratories Ltd • Updated: 2025-09-16 20:11:24
-
10BusinessHighPharmaceutical sector is essential but faces regulatory challenges.
-
10GrowthHighModerate revenue growth observed, but inconsistent profit margins.
-
8ProfitabilityHighROE and ROCE are below industry averages.
-
10ValuationHighP/E ratio is higher than peers, indicating potential overvaluation.
-
7BalanceHighDebt levels are manageable, but liquidity is a concern.
-
6GovernanceGoodPromoter holding is decent, but some pledging exists.
-
5DriversGoodLimited growth catalysts identified, execution risks are present.
-
0TechnicalsLowWeak market sentiment and low liquidity.
Final Score & Verdict
Score 48 / 100
• Risky
Chemo Pharma Laboratories Ltd presents several risks with limited growth prospects and profitability concerns, making it a risky investment.
AI Confidence Score
Instead of just “overall score,” broken into categories:
- Business Strength: 75/100
- Growth Potential: 70/100
- Profitability: 65/100
- Governance: 80/100
- Market Confidence: 72/100